Fumarate hydratase-deficient renal cell carcinoma: a case report and review of the literature

BACKGROUND: Fumarate hydratase-deficient renal cell carcinoma is a rare pathological subtype that was defined by the World Health Organization (WHO 5th edition) in 2022. At present, only a few hundreds of cases have been reported worldwide, mainly in Europe and the United States. A case of a Chinese...

Descripción completa

Detalles Bibliográficos
Autores principales: Lv, Yanting, Song, Lide, Hu, Mengjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10116832/
https://www.ncbi.nlm.nih.gov/pubmed/37076922
http://dx.doi.org/10.1186/s13256-023-03841-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10116832/
https://www.ncbi.nlm.nih.gov/pubmed/37076922
http://dx.doi.org/10.1186/s13256-023-03841-0

Ejemplares similares